CAGLIUSO, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 758
EU - Europa 208
AS - Asia 83
SA - Sud America 16
AF - Africa 3
Totale 1.068
Nazione #
US - Stati Uniti d'America 753
SE - Svezia 71
IT - Italia 54
IN - India 31
CN - Cina 27
SG - Singapore 25
UA - Ucraina 22
FI - Finlandia 20
AR - Argentina 14
DE - Germania 11
GB - Regno Unito 11
IE - Irlanda 8
CA - Canada 4
BE - Belgio 3
RO - Romania 3
BG - Bulgaria 2
TG - Togo 2
BR - Brasile 1
CI - Costa d'Avorio 1
CL - Cile 1
GR - Grecia 1
MX - Messico 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 1.068
Città #
Fairfield 106
Chandler 89
Ashburn 65
Woodbridge 56
Houston 46
Cambridge 42
Seattle 42
Wilmington 42
Ann Arbor 30
Princeton 21
San Paolo di Civitate 20
Plano 19
Dearborn 17
Lawrence 13
Beijing 12
Federal 12
Los Angeles 12
Singapore 12
Boston 10
Jacksonville 9
Rome 9
Boardman 8
Dublin 8
Millbury 8
San Diego 6
Norwalk 5
Andover 4
Florence 4
Toronto 4
Brussels 3
Fremont 3
Kilburn 3
Nanjing 3
Bremen 2
Buenos Aires 2
Falkenstein 2
Hefei 2
Kunming 2
Lamezia Terme 2
Laurel 2
Lomé 2
Mannheim 2
Provo 2
Redmond 2
Sofia 2
Southend 2
Velletri 2
Abidjan 1
Americana 1
Bari 1
Belgrade 1
Bologna 1
Buffalo 1
Chaoyang 1
Charlotte 1
Chengdu 1
Des Moines 1
Falls Church 1
Frankfurt am Main 1
Genova 1
Grafing 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Indiana 1
Jesi 1
Lamézia 1
Mexico City 1
Milan 1
Pune 1
Redwood City 1
Romola 1
San Mateo 1
Seversk 1
Shenyang 1
Washington 1
Zhengzhou 1
Totale 801
Nome #
The VH1-69-expressing marginal zone B cells expanded in HCV-associated mixed cryoglobulinemia display proliferative anergy irrespective of CD21low phenotype. 98
Clonal B cells of HCV-associated mixed cryoglobulinemia patients contain exhausted marginal zone-like and CD21 low cells overexpressing Stra13 82
B LYMPHOCYTE SUBSETS AND THEIR FUNCTIONAL ACTIVITY IN THE EARLY MONTHS OF LIFE 81
Persistence of a Large Population of Exhausted Monoclonal B cells in Mixed Cryoglobuliemia After the Eradication of Hepatitis C Virus Infection 77
Regression of Systemic Lupus Erythematosus After Development of an Acquired Toll-like Receptor Signaling Defect and Antibody Deficiency 71
Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication 68
UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE - AN UNSOLVED PROBLEM: REVISION OF LITERATURE AND CASE STUDIES 65
Lithiasis of semicircular canals and parotid glands: unusual stones deposition in atazanavir-treated individuals. 64
IMPIEGHI CLINICI DELLE IMMUNOGLOBULINE PER VIA ENDOVENOSA (IVIgG) IN PAZIENTI AFFETTI DA MALATTIA DA HIV-1 59
CpG drives human transitional B cells to terminal differentiation and production of natural antibodies 59
Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis 55
Interleukin-2 therapy in patients with HIV infection. 54
B-cell memory defect in a SLE induced a severe antibody, stable clinical remission and succesful renal transplantation 50
Telomere-dependent replicative senescence of B and T cells from patients with type 1a common variable immunodeficiency 46
The CD21low B Cells Expanded in Common Variable Immunodeficiency do not Differentiate to Antibody Producing Cells After Stimulation of Toll-like Receptor 9 Because of a Reduced Proliferative Potential 41
Defective proliferative response of B-lymphocytes upon stimulation of TLR7 and TLR9 in common variable immune deficiency 37
L'Immunodeficinza Comune Variabile 28
Ig levels and B cell differenziative capacity predict the risk of acute infections in CVID 26
Replicative senescence prevents the differentiation of B-cells to antibody producine cells in common variable immunodeficiency 19
Totale 1.080
Categoria #
all - tutte 3.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020220 0 0 0 13 28 39 42 34 31 17 8 8
2020/202157 4 10 1 5 3 3 2 8 6 8 7 0
2021/2022184 1 10 21 6 25 4 6 16 19 15 22 39
2022/2023281 39 61 9 44 31 34 1 15 33 0 5 9
2023/202497 7 15 3 12 7 6 5 3 0 21 9 9
2024/202514 5 1 7 1 0 0 0 0 0 0 0 0
Totale 1.080